Company Filing History:
2 out of 8,373 
1 out of 443 
1 out of 1,455 
Years Active: 2025
Title: David Cox: Innovator in CRISPR Technology
Introduction
David Cox is a prominent inventor based in Cambridge, MA (US). He is known for his significant contributions to the field of genetic engineering, particularly in the development of CRISPR technology. His innovative work has led to advancements in the identification of novel CRISPR effectors, which are crucial for various applications in biotechnology and medicine.
Latest Patents
David Cox holds a patent titled "Methods for identifying class 2 CRISPR-Cas systems." This patent discloses a method for identifying novel CRISPR effectors. The method involves identifying sequences in a genomic or metagenomic database that encode a CRISPR array. It also includes identifying one or more Open Reading Frames (ORFs) within 10 kb of the CRISPR array, discarding loci encoding proteins assigned to known CRISPR-Cas subtypes, and identifying putative novel CRISPR effectors based on structural analysis. He has 1 patent to his name.
Career Highlights
Throughout his career, David Cox has worked with esteemed organizations such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. His work at these institutions has allowed him to collaborate with leading scientists and contribute to groundbreaking research in the field of genetics.
Collaborations
David has collaborated with notable colleagues, including Sergey Shmakov and Kira S. Makarova. These collaborations have further enhanced his research and innovation in CRISPR technology.
Conclusion
David Cox is a key figure in the advancement of CRISPR technology, with a focus on identifying novel CRISPR effectors. His contributions have the potential to impact various fields, including medicine and biotechnology.